Abstract:93 Background: Nasopharyngeal carcinoma (NPC) is a malignant tumor occurring in the epithelium of nasopharyngeal mucosa. Radiotherapy can achieve a good therapeutic effect for NPC in situ. However, there is no effective treatment once distant metastasis occurring. Epstein-Barr virus (EBV) is an important pathogenic factor of NPC and also promotes tumor metastasis. The passage of circulating tumor cells through the vascular barrier is one of the rate-limiting steps of tumor distant metastasis, and vascular endothelial cells are an important component. Exosomes are an important way of information transmission between cells. And some small molecules in exosomes involve in tumor metastasis. How the exosomes of NPC cells affect vascular endothelial cells and promote metastasis has not been studied. Therefore, it is of great significance to explore the effect of the NPC exosomes with EBV component on the vascular endothelial cells of metastatic foci and the mechanism of promoting tumor metastasis, in order to find effective therapeutic targets and molecular markers indicating distant metastasis. Methods: 1. Immunohistochemical analysis was used to analyze the vascular endothelium of liver and lung tissues with NPC metastasis compared with that of non-tumor liver and lung in pathological sections; 2. Using transmission electron microscope, cells and dye molecules through vascular endothelial cell monolayer experiment, immunofluorescence and animal tumorigenesis experiment to detect the effect of NPC exosomes on vascular endothelial cells and NPC metastasis; 3. Using CRISPR-Cas9 knockout EBNA1, cell function test and miRNA sequencing technology to analyze to analyze molecular types that induce vascular endothelial cell pyroptosis in NPC exosomes; 4. Using bioinformatics prediction, luciferase reporter gene, immunofluorescence and animal tumorigenesis experiment to further clarify the molecular pathway of molecules in the NPC exosomes that induce endothelial cell pyroptosis. Results: 1. Immunohistochemistry showed that P20 and NT-GSDMD were significantly higher in vascular endothelial cells of liver and lung tissues with NPC metastasis than in non-tumor liver and lung; 2. NPC exosomes can promote the increase of molecules related to vascular endothelial cell pyroptosis (P20, NT-GSDMD and IL-1 β), the formation of vesicular protrusion of cell membrane and the destruction of vascular endothelial monolayer barrier. And vascular endothelial cell pyroptosis can promote the migration of circulating tumor cells out of blood vessels to form metastatic foci; 3. BART2-5p in NPC exosomes is the main effector molecule that induces vascular endothelial cell pyroptosis; 4. MRE11A is the target molecule of BART2-5p to induce vascular endothelial cell pyroptosis. Conclusions: 1. It was found for the first time that the vascular endothelial cell pyroptosis in liver and lung metastasis of NPC; 2. It is proved that BART2-5p in NPC exosomes is involved in regulating the vascular endothelial cell pyroptosis, and promoting NPC cells to go through blood vessels and form metastatic foci; 3. MRE11A mediates BART2-5p to induce the vascular endothelial cell pyroptosis.

Platelet-derived extracellular vesicles inhibit ferroptosis and promote distant metastasis of nasopharyngeal carcinoma by upregulating ITGB3

As an Independent Unfavorable Prognostic Factor, IL-8 Promotes Metastasis of Nasopharyngeal Carcinoma Through Induction of Epithelial–mesenchymal Transition and Activation of AKT Signaling

Four-dimensional trapped ion mobility spectrometry proteomics reveals circulating extracellular vesicles encapsulated drivers of nasopharyngeal carcinoma distant dissemination

Effect of exosomes from nasopharyngeal carcinoma on endothelium pyroptosis and metastasis.

Exosomal MIF Derived From Nasopharyngeal Carcinoma Promotes Metastasis by Repressing Ferroptosis of Macrophages

Tumor-derived EBV-miR-BART2-5p promotes nasopharyngeal carcinoma metastasis by inducing pre-metastatic endothelial cell pyroptosis

Matrix metalloproteinase 13‐containing exosomes promote nasopharyngeal carcinoma metastasis

PFKFB3 promotes proliferation, migration and angiogenesis in nasopharyngeal carcinoma.

LMP1-positive extracellular vesicles promote radioresistance in nasopharyngeal carcinoma cells through P38 MAPK signaling

Targeting the PLUNC-NLRP3 inflammasome axis could inhibit nasopharyngeal carcinoma lung metastasis

The ferroptosis signature predicts the prognosis and immune microenvironment of nasopharyngeal carcinoma

SCARB1 in extracellular vesicles promotes NPC metastasis by co-regulating M1 and M2 macrophage function

P4HA1 activates HMGCS1 to promote nasopharyngeal carcinoma ferroptosis resistance and progression

The CXCL5/CXCR2 axis contributes to the epithelial-mesenchymal transition of nasopharyngeal carcinoma cells by activating ERK/GSK-3β/snail signalling

c-Src activation promotes nasopharyngeal carcinoma metastasis by inducing the epithelial-mesenchymal transition via PI3K/Akt signaling pathway: a new and promising target for NPC.

YPEL3 Suppresses Epithelial–mesenchymal Transition and Metastasis of Nasopharyngeal Carcinoma Cells Through the Wnt/β-catenin Signaling Pathway

LACTB promotes metastasis of nasopharyngeal carcinoma via activation of ERBB3/EGFR-ERK signaling resulting in unfavorable patient survival

The miRNA-185-5p/STIM1 Axis Regulates the Invasiveness of Nasopharyngeal Carcinoma Cell Lines by Modulating EGFR Activation-Stimulated Switch from E- to N-Cadherin

Upregulation of PNCK Promotes Metastasis and Angiogenesis Via Activating NF-κB/VEGF Pathway in Nasopharyngeal Carcinoma

PEDF Inhibits Lymphatic Metastasis of Nasopharyngeal Carcinoma As a New Lymphangiogenesis Inhibitor

Vimentin is a Crucial Target for Anti-Metastasis Therapy of Nasopharyngeal Carcinoma